Detail akcie China Pharm online

Business Summary: CSPC Pharmaceutical Group Limited is an investment holding company principally engaged in the manufacture and sales of pharmaceutical products. The Company sells its products under the brand of CSPS. The Company has four business segments: Finished Drugs, Antibiotics (intermediates and bulk drugs), Vitamin C (bulk drugs) and Caffeine and Others (bulk drugs). All these segments are engaged in the manufacture and sales of related pharmaceutical products. The finished drugs include the antibiotics, cardio-cerebrovascular drugs, diabetes drugs, neurology drugs, oncology drugs and traditional Chinese medicines. The Company is also engaged in the provision of pharmaceutical research and development services, as well as the processing of sewage and pharmaceutical by-products through its subsidiaries.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2023, CSPC Pharmaceutical Group Ltd revenues increased 2% to RMB31.45B. Net income decreased 4% to RMB5.87B. Revenues reflect Finished Drugs segment increase of 5% to RMB25.64B, Functional Food and Others segment increase of 26% to RMB2.47B, Antibiotics segment increase of 5% to RMB2.01B, The People's Republic of China segment increase of 4% to RMB27.18B, Others segment increase of 85% to RMB524.8M.